-- Predicting the Course of Alzheimer's

New York, NY
 – July 11, 2012 /Press Release/  –– 

For the first time, scientists and doctors have a clear picture of when different changes in the body come along, presenting tantalizing targets for drug research, which can be aimed at patients who have not yet developed symptoms of Alzheimer’s disease. Many Alzheimer's researchers say this is a big deal. "[The new data] are significant in planning primary prevention trials, meaning starting a drug before any detectable disease [develops]," said Dr. Samuel Gandy, Associate Director at the Mount Sinai Alzheimer's Disease Research Center in New York.  Learn more